1. Prediction of the efficacy of a medicament on renal or cardiovascular clinical outcomes

   Lambers Heerspink, H. J., Zeeuw, de, D. & Grobbee, D. E., 22-Aug-2013, Patent No. WO2013122469, 18-Feb-2013, Priority date 17-Feb-2012

   Research output: Patent › Professional

2. No significant association of type 2 diabetes-related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives

   Martono, D. P., Heerspink, H. J. L., Hak, E., Denig, P. & Wilffert, B., 5-Jun-2019, In : Diabetes obesity & metabolism. 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Future and Novel Compounds in the Treatment of Diabetic Nephropathy

   Idzerda, N., Pena, M., de Zeeuw, D. & Heerspink, H., 2019, Diabetic Nephropathy: Pathophysiology and Clinical Aspects. Roelofs, J. & Vogt, L. (eds.). Springer, p. 515-539 540 p.

   Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

4. Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors

   Eickhoff, M. K., Dekkers, C. C. J., Kramers, B. J., Laverman, G. D., Frimodt-Møller, M., Jørgensen, N. R., Faber, J., Danser, A. H. J., Gansevoort, R. T., Rossing, P., Persson, F. & Heerspink, H. J. L., 2019, In : Journal of Clinical Medicine. 8, 6, 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

   Pollock, C., Stefansson, B., Reyner, D., Rossing, P., Sjostrom, C. D., Wheeler, D. C., Langkilde, A. M. & Heerspink, H. J. L., Jun-2019, In : Lancet Diabetes & Endocrinology. 7, 6, p. 429-441 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (260) »

1. Basis principes in farmacokinetiek van geneesmiddelen en invloed van obesitas

   Jasper Stevens (Speaker), Hiddo Heerspink (Speaker)

   29-Jan-2019

   Activity: Talk or presentation › Professional

2. Challenges with Personalized Medicine

   Hiddo Lambers Heerspink (Speaker)

   Oct-2018

   Activity: Talk or presentation › Professional

3. Invited lecture Annual Society of Japanese Diabetes Association

   Hiddo Lambers Heerspink (Speaker)

   Oct-2018

   Activity: Talk or presentation › Professional

View all (13) »